Form 4: Arteris CEO Charles Janac Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Arteris CEO Charles Janac sold a total of 20,256 shares of common stock on December 11th and 12th, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Charles Janac, the President and CEO of Arteris, Inc., sold 2,400 shares of common stock on December 11, 2024, at a weighted average price of $10.0075 per share.
- On December 12, 2024, Mr. Janac sold an additional 17,856 shares at a weighted average price of $10.1225 per share.
- These transactions were executed under a 10b5-1 trading plan adopted on February 27, 2024.
- Following these sales, Mr. Janac directly owns 274,776 shares and indirectly owns 10,287,435 shares through Bayview Legacy, LLC, and 77,286 shares through the Janac Trust.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock sales by an executive under a pre-arranged plan, which is neither positive nor negative in itself. It is a neutral event.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, potentially impacting investor sentiment.
Industry Context
This is a routine disclosure of stock sales by a company executive, which is common in publicly traded companies. The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- Executive stock sales are a common occurrence in publicly traded companies, and the use of a 10b5-1 trading plan is a standard practice to ensure compliance with insider trading regulations.
- Many technology companies have executives who utilize similar trading plans to manage their personal finances and diversify their holdings.
- The volume of shares sold by Mr. Janac is not unusual for an executive of a company of Arteris' size.
Stakeholder Impact
- The stock sales may have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date the 10b5-1 trading plan was adopted by Charles Janac. |
| 12/11/2024 | Date of the first stock sale transaction. |
| 12/12/2024 | Date of the second stock sale transaction. |
| 12/13/2024 | Date the Form 4 was signed. |
Keywords
Arteris, Charles Janac, stock sale, 10b5-1 trading plan, insider trading, executive stock, Bayview Legacy LLC, Janac Trust
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.